U.S. Water Utilities Stock News

Piedmont Realty Trust announced it will release its fourth-quarter and full-year 2025 results on February 11, 2026, alongside a management conference call the following day to discuss performance and recent activity. The company reported leasing 2.5 million square feet in 2025, much of it to new tenants at record rental rates, highlighting the impact of its portfolio upgrades and capital structure moves, including a US$532.5 million tender offer and new US$400 million senior notes. We’ll now...

Bristlemoon Capital’s recently released Q4 2025 investor letter highlighted Floor & Decor Holdings’ multi‑year growth in comparable store sales and revenue, as well as its 5.5% third‑quarter sales increase. The letter underscored Floor & Decor’s emphasis on private label flooring and large warehouse-format stores as a key edge over big box home improvement chains, even though it is not among the most widely held hedge fund names. We’ll now examine how Bristlemoon’s emphasis on Floor &...

In recent months, Brookfield Infrastructure Partners has been trading near its 52-week low as investors reassess the impact of higher interest rates on its capital-intensive portfolio of utilities, transport, midstream, and data assets. At the same time, management’s push to recycle capital from mature holdings into data infrastructure and midstream energy is reshaping the business mix and drawing cautiously positive attention from Wall Street analysts. We’ll now examine how Brookfield...

In early January 2026, GTT Communications announced that Constellium renewed its GTT SIP Trunking agreement, connecting more than 15 sites across Europe and North America to support secure, unified voice and Microsoft Teams communications. At the same time, management highlighted benefits from widening scrap spreads and operational improvements at the Muscle Shoals facility, signaling a stronger focus on efficiency and recycling-driven cost advantages. We’ll now examine how Constellium’s...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

Willis Lease Finance Corporation ( NASDAQ:WLFC ) shareholders have had their patience rewarded with a 25% share price...

While The Brink's Company ( NYSE:BCO ) might not have the largest market cap around , it saw a double-digit share price...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

It hasn't been the best quarter for RF Industries, Ltd. ( NASDAQ:RFIL ) shareholders, since the share price has fallen...

IDEX Corporation ( NYSE:IEX ) stock is about to trade ex-dividend in 2 days. The ex-dividend date occurs one day before...

It's nice to see the Gibraltar Industries, Inc. ( NASDAQ:ROCK ) share price up 10% in a week. But if you look at the...

Gray Media, Inc. ( NYSE:GTN ), is not the largest company out there, but it saw significant share price movement during...

Despite an already strong run, FormFactor, Inc. ( NASDAQ:FORM ) shares have been powering on, with a gain of 32% in the...

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Apyx Medical fair value estimate is US$7.24 Apyx Medical is...

Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But in contrast you can...

Wheels Up Experience (UP) is back in focus after receiving a NYSE notice about its sub US$1 share price, outlining cost reduction plans and expanding its Delta Air Lines partnership to let members book Delta flights through its portal. See our latest analysis for Wheels Up Experience. The NYSE notice and the expanded Delta partnership come after a sharp rebound in the 1 day share price return of 46.58% and a 7 day share price return of 44.45%. However, the 1 year total shareholder return...

Xometry (XMTR) is back in focus after announcing new high performance additive manufacturing materials, enhanced controls in its Instant Quoting Engine, and additional buyer options that closely align with aerospace, defense, and automotive needs. See our latest analysis for Xometry. At a share price of US$64.06, Xometry has seen a 10.45% 1 month share price return and 31.57% 3 month share price return. Its 1 year total shareholder return of 92.43% points to momentum that has been building...

Warrior Met Coal (HCC) just marked a major milestone by celebrating completion of its Blue Creek Mine after a roughly US$1b investment that materially expands metallurgical coal capacity and supporting logistics infrastructure in Alabama. See our latest analysis for Warrior Met Coal. The Blue Creek Mine milestone comes after a strong run in Warrior Met Coal’s shares, with a 90 day share price return of 49.06% and a 1 year total shareholder return of 87.35%, suggesting momentum has been...

In early January 2026, Wolfe Research downgraded Gulfport Energy Corporation from “Outperform” to “Peer Perform” after lowering its long-term US natural gas price assumptions, while US natural gas futures also fell to a 10-week low on warmer weather and softer heating demand. This combination of a more cautious analyst stance and weaker commodity pricing expectations has sharpened investor focus on Gulfport’s sensitivity to long-term natural gas fundamentals. We’ll now examine how Wolfe...

Xencor recently outlined its 2026 priorities and advancement milestones for its clinical-stage XmAb drug portfolio, highlighting progress across oncology and autoimmune programs, including early anti-tumor activity and tolerability for its lead T-cell engagers. An important takeaway for investors is Xencor’s expectation that its current cash resources should fund research and operations through 2028, supporting multiple planned pivotal studies without near-term financing guidance. We’ll now...

Zenas BioPharma (ZBIO) has been in focus after reporting positive Phase 3 INDIGO results for obexelimab in IgG4-Related Disease, followed by sharp share price volatility and a recent US$1.63 million CEO share purchase. See our latest analysis for Zenas BioPharma. The recent 1-day share price return of 23.01% and 7-day share price return of 30.13% suggest short term momentum following the INDIGO data and CEO buying. However, the 30-day share price return of 51.27% and year to date share price...